Home
Live
News
Create
Screeners
Insights
Indrayani Biotech
15.
10
-0.27
(-1.76%)
Market Cap
₹70.00 Cr
PE Ratio
-10.17
Industry
FMCG
Buy
Sell
Company Performance:
1D
-1.76%
1M
+27.21%
6M
-24.50%
1Y
-61.88%
5Y
+63.42%
View Company Insights
Latest news about Indrayani Biotech
Indrayani Biotech Secures BSE In-Principle Approval for Rights Issue of Partly Paid-up Equity Shares
Sep 20, 2025
Indrayani Biotech Limited has received in-principle approval from BSE Limited for a proposed rights issue of partly paid-up equity shares. The approval, dated September 19, 2025, with reference number LOD/RIGHT/TT/FIP/920/2025-26, was announced through a regulatory filing signed by the company's Whole-time Director, Swaminathan G. The company officially informed BSE about the approval on September 20, 2025, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Indrayani Biotech is listed on BSE with scrip code 526445.
Indrayani Biotech's Subsidiary Secures SEBI Approval for Category II Alternative Investment Fund
Sep 16, 2025
Indrayani Biotech Reports Mixed Q1 Results: Standalone Profit Steady, Consolidated Revenue Declines
Aug 15, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation